J. Mcelroy

Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.

B. Largent, A. Robichaud, D. Robertson, 2003, Bioorganic & medicinal chemistry letters.

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist.

G. Trainor, A. Cocuzza, D. Robertson, 2000, Bioorganic & medicinal chemistry.